Donate For Public and Patients Store Search

F104 - The Science of Cosmeceuticals and Nutraceuticals

Sunday, March 3; 3:30 PM - 5:30 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Examine the role of nutraceuticals in skin health.
  • Assess the value of cosmeceuticals in skin appearance.
  • Demonstrate an understanding of cosmeceuticals in skin of color.

Description

This innovative session examines the role of cosmeceuticals and nutraceuticals in dermatology. Much media attention has been focused on eating to achieve skin health. An in depth examination of foods, supplements and their purported benefits will be presented. Cosmeceuticals lead patients to believe that one special formulation can create healthy skin. Skin care products for all Fitzpatrick skin types will be evaluated for their dermatologic value. At the conclusion of this session, participants will obtain up-to-date diet and skin care ideas for implementation into clinical practice with ample time for audience questions.

Disclosures

  • Berson, Diane S., MD: Aclaris Therapeutics Inc. – C(H); Allergan, Inc – C(H); Almirall – A(H); Ferndale Laboratories, Inc. – C(H); Galderma Laboratories, L.P. – A(H); La Roche-Posay Laboratoire Pharmaceutique – A(H); Ortho Dermatologics – A(H); Procter & Gamble Company – C(H); Revance Therapeutics, Inc. – A(H); Sienna Biopharmaceuticals – A(H); Skinfix, Inc. – A(H); Taro Pharm – A(H); TopMD – C(H);
  • Draelos, Zoe Diana, MD: Abbott Laboratories – I(Grants/Research Funding); Actavis – I(Grants/Research Funding); AGI Dermatics – I(Grants/Research Funding); Allergan, Inc. – I(Grants/Research Funding); AmDerma Pharmaceuticals, LLC – I(Grants/Research Funding); Amgen – I(Grants/Research Funding); Amneal Pharmaceuticals, LLC – I(Grants/Research Funding); AstraZeneca – I(Grants/Research Funding); Avon Products, Inc. – I(Grants/Research Funding); Bayer – I(Grants/Research Funding); Bayer Consumer Healthcare Pharmaceuticals – I(Grants/Research Funding); Beiersdorf, Inc. – I(Grants/Research Funding); Boots – C(Grants/Research Funding); Celgene Corporation – I(Grants/Research Funding); Chattem, Inc. – I(Grants/Research Funding); Colgate-Palmolive – I(Grants/Research Funding); Dermira – I(Grants/Research Funding); Dial Corporation – I(Grants/Research Funding); Eli Lilly and Company – I(Grants/Research Funding); Elizabeth Arden – I(Grants/Research Funding); Exeltis – I(Grants/Research Funding); Galderma Laboratories, L.P. – I(Grants/Research Funding); GlaxoSmithKline – I(Grants/Research Funding); Glenmark Generics Inc. – I(Grants/Research Funding); Guthy-Renker – I(Grants/Research Funding); Helix BioMedix – I(Grants/Research Funding); Johnson & Johnson Consumer Products Company – I(Grants/Research Funding); Kao Brands – I(Grants/Research Funding); Kimberly Clark – I(Grants/Research Funding); Kythera – I(Grants/Research Funding); L'Oreal USA Inc. – I(Grants/Research Funding); La Roche-Posay Laboratoire Pharmaceutique – I(Grants/Research Funding); Lexington International LLC – I(Grants/Research Funding); Living Proof, Inc – I(Grants/Research Funding); Lumity – I(Grants/Research Funding); MakuCell, Inc. – I(Grants/Research Funding); Maruho Co., Ltd – I(Grants/Research Funding); Medicis Pharmaceutical Corporation – I(Grants/Research Funding); Merck & Co., Inc. – I(Grants/Research Funding); Merz Pharmaceuticals, LLC – I(Grants/Research Funding); Mimetica Pty. Limited – I(Grants/Research Funding); Neocutis – I(Grants/Research Funding); Neutrogena Corporation – I(Grants/Research Funding); Niadyne – I(Grants/Research Funding); Novartis Pharmaceuticals Corp. – I(Grants/Research Funding); Nuskin – I(Grants/Research Funding); Oculus – I(Grants/Research Funding); Onset Therapeutics – I(Grants/Research Funding); Otsuka Pharmaceutical Co., Ltd. – I(Grants/Research Funding); Pacific Biosciences – I(Grants/Research Funding); Perrigo Company – I(Grants/Research Funding); Pfizer Inc. – I(Grants/Research Funding); Procter & Gamble Company – I(Grants/Research Funding); Promius Pharma, LLC – I(Grants/Research Funding); Quinnova Pharmaceuticals, Inc. – I(Grants/Research Funding); Ranbaxy Laboratories Limited – I(Grants/Research Funding); RECKITT BENCKISER (ESPA√ĎA), S.L. – I(Grants/Research Funding); Revance Therapeutics, Inc. – I(Grants/Research Funding); Revision Skincare – I(Grants/Research Funding); Signum Biosciences, Inc. – I(Grants/Research Funding); SkinMedica, Inc. – I(Grants/Research Funding); Sun Products Corporation – I(Grants/Research Funding); Suneva Medical, Inc. – I(Grants/Research Funding); Symrise – I(Grants/Research Funding); Syneron, Inc. – I(Grants/Research Funding); Taro Pharm – I(Grants/Research Funding); Teva Pharmaceuticals USA – I(Grants/Research Funding); Tolmar – I(Grants/Research Funding); Valeant Pharmaceuticals International – I(Grants/Research Funding); Vichy Laboratoires – I(Grants/Research Funding);
  • Farris, Patricia, MD: Aclaris Therapeutics Inc. – A(H); Bausch Health – A(H); Dermira – SP(H); La Roche-Posay Laboratorie Pharmaceutique – A(H); Neostrata – C(H); Nestle – C(H); Nutraceutical Wellness, LLC. – A(SO); Regimen MD – F(ST); Sente Labs – SP(H); SkinCeauticals LLC – A(H); U.SK Under Skin – C(Fees);
  • Taylor, Susan C., MD: Aclaris Therapeutics, Inc. – A(H), I(Grants/Research Funding), SP(H); Allergan, Inc – A(H), Speaker/Faculty Education(NC); Almirall – A(H); Avon Products, Inc. – C(H); Beiersdorf, Inc. – A(H), C(H), Speaker/Faculty Education(H); Boots – A(H); CannTec – B(H); Croma-Pharma GmbH Austria – I(Grants/Research Funding); Eli Lilly and Company – I(Grants/Research Funding); Galderma Laboratories, L.P. – A(H); Galderma Laboratories, LP – Speaker/Faculty Education(H); Johnson & Johnson Consumer Products Company – A(H); KGL Skin Study Center – Independent Contractor(S); Neostrata – C(H); Unilever – SP(H);
Schedule
Sunday, March 3
3:30 PM
Dr. Draelos / Nutraceuticals: Is It Possible to Eat Your Way to Skin Health
3:50 PM
Dr. Draelos / Questions and Answers
4:00 PM
Dr. Berson / A New Cosmeceutical for Estrogen Deficient Skin
4:20 PM
Dr. Berson / Questions and Answers
4:30 PM
Dr. Farris / Probiotics, Prebiotics and Other Nutraceutical Trends
4:50 PM
Dr. Farris / Questions and Answers
5:00 PM
Dr. Taylor / Skin of Color Cosmeceutical Considerations
5:20 PM
Dr. Taylor / Questions and Answers
Event Details
  • Date
    Sunday, March 3
  • Time
    3:30 PM - 5:30 PM
  • Location
    Ballroom A
  • CME Credits
    2.00
  • Type
Directors/Co-Directors
Speakers
  • Diane S. Berson, MD, FAAD - Handout
  • Patricia Farris, MD, FAAD
  • Susan C. Taylor, MD, FAAD